drugset / Trial / NCT02818036

An fMRI Study of Opioid-related Changes in Neural Activity

NCT02818036 ↗

Completed 82 enrolled Tristen Inagaki
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of the study is to explore the effect of blocking opioids on affiliation-related neural activity.

Timeline

Start
2016-08
Primary completion
2018-06-21
Completion
2018-06-21

Outcome

Mixed primary results

registry MEAN Naltrexone: 0.117 (Standard Error 0.033) BOLD signal NCT02818036 ↗

registry MEAN Sugar Pill: 0.2545 (Standard Error 0.061) BOLD signal NCT02818036 ↗

registry analysis (other test); Naltrexone vs Sugar Pill; p <.01; t-test, 1 sided; note: a priori threshold for significance was p\<.05 NCT02818036 ↗

registry analysis (other test); Naltrexone vs Sugar Pill; p = .338; t-test, 2 sided; note: a priori threshold for statistical significance was p\<.05 NCT02818036 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg Oral

Indications

No indication recorded.